iifl-logo

SBI Healthcare Opportunities Fund G

SBI Healthcare Opportunities Fund G

Fund Name

SBI Mutual Fund

Scheme Name

SBI Healthcare Opportunities Fund G

AMC

SBI Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

04-Jun-1999

Fund Manager

Tanmaya Desai

Net Assets (Rs. cr)

4323.29

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

SBI Healthcare Opportunities Fund G - Nav Details

Nav Date

:  07-Jun-2026

NAV [Rs.]

:  -

Buy/Resale Price [Rs.]

-

Sell/Repurchase Price [Rs.]

-

Entry Load %

Exit Load %

SBI Healthcare Opportunities Fund G- NAV Chart

SBI Healthcare Opportunities Fund G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
-0.41
3.19
8.76
7.04
10.33
24.62
15.29
15.22
Category Avg
-1.48
3.96
6.4
5.15
10
23.45
13.95
14.83
Category Best
-0.02
6.29
10.67
11.79
20.13
27.28
16.38
29.32
Category Worst
-2.63
-0.92
-0.53
-2.66
1.77
19.09
10.35
-1.67

SBI Healthcare Opportunities Fund G- Latest Dividends

No Records Found

SBI Healthcare Opportunities Fund G- Investment Details

Min. Investment(Rs.)

5000

Increm.Investment(Rs.)

1000

In & Out

In

InName Of The CompanyNo Of Shares
--

Out

InName Of The CompanyNo Of Shares
Vijaya Diagnost.2,50,000
Corona Remedies75,000

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology11.712800000506.32
EquityDivi's Lab.Pharmaceuticals & Biotechnology6.77450000292.61
EquityAcutaas ChemicalPharmaceuticals & Biotechnology5.40900000233.46
EquityApollo HospitalsHealthcare Services5.30300000229.09
EquityMax HealthcareHealthcare Services5.172250000223.43
EquityAster DM Health.Healthcare Services3.892400000168.25
EquityLupinPharmaceuticals & Biotechnology3.84720000165.97
EquityTorrent Pharma.Pharmaceuticals & Biotechnology3.48360000150.66
EquityAnthem BiosciencPharmaceuticals & Biotechnology3.451962504149.16
EquityAether Industri.Chemicals & Petrochemicals3.351235202144.74
EquityMankind PharmaPharmaceuticals & Biotechnology3.33640000143.78
EquityAurobindo PharmaPharmaceuticals & Biotechnology3.211000000138.95
EquityFortis Health.Healthcare Services3.201500000138.44
EquityBioconPharmaceuticals & Biotechnology3.123750000134.86
EquityLaurus LabsPharmaceuticals & Biotechnology3.061200000132.11
Foreign EquityLonza GroupPharmaceuticals & Biotechnology2.71200000117.01
EquityJupiter Life LinHealthcare Services2.55900000110.33
EquityAlkem LabPharmaceuticals & Biotechnology2.50200000108.00
EquitySai LifePharmaceuticals & Biotechnology2.471000000106.94
EquityKrishna Institu.Healthcare Services2.471600000106.67
EquityGland PharmaPharmaceuticals & Biotechnology2.43600000105.04
EquityPoly MedicureHealthcare Equipment & Supplies2.2464000096.77
EquitySudeep PharmaChemicals & Petrochemicals2.23136000096.22
EquityAjanta PharmaPharmaceuticals & Biotechnology1.9630000084.68
EquityConcord BiotechPharmaceuticals & Biotechnology1.9072000082.22
EquityAbbott IndiaPharmaceuticals & Biotechnology1.472500063.58
EquityCohance LifePharmaceuticals & Biotechnology1.12100000048.32
EquityNephrocare HealtHealthcare Services0.9880000042.34
EquityRainbow Child.Healthcare Services0.8730000037.56
EquityGufic BioSciencePharmaceuticals & Biotechnology0.4670474120.05
EquitySanofi ConsumerPharmaceuticals & Biotechnology0.444000019.05
EquityMedplus HealthRetailing0.3015000013.08

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
SBI Mutual Fund
Incorporation Date:
07-Feb-1992
Total Assets Managed (Cr.):
12,70,599.37
Trustee/s:
Sandra Martyres, Bharati Rao, Smt. Manju Agarwal, SBI Mutual Fund Trustee C, Richard Mendonca, Mr. Dhruv Prakash
Chairman:
NA
CEO / MD:
Nand Kishore
CIO:
NA
President:
NA
Director/s:
Om Prakash Gahrotra, Dr. Prafulla Agnihotri, Mrs. Madhu Dubhashi
Compliance Officer/s:
NA
Investor Service Officer/s:
NA
Fund Manager/s:
Tanmaya Desai
Auditors:
Sudit K Parekh & Co, M/S Chandabhoy&Jassoobhoy

OTHER INFORMATION

Registered Office:
9th Floor,Crescenzo, C-39&39, G Block, Bandra kurla complex, Bandra (east), Mumbai-400 051.
Contact Nos:
022-61793000
Fax:
022-67425687
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.